SynAct Pharma AB (OSTO:SYNACT) 3-Year Book Growth Rate : 97.10% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SynAct Pharma AB 3-Year Book Growth Rate?

SynAct Pharma AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr4.28.

During the past 12 months, SynAct Pharma AB's average Book Value per Share Growth Rate was -49.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 97.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 54.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 8 years, the highest 3-Year average Book Value per Share Growth Rate of SynAct Pharma AB was 97.10% per year. The lowest was -26.80% per year. And the median was 7.30% per year.

Competitive Comparison of SynAct Pharma AB's 3-Year Book Growth Rate

For the Biotechnology subindustry, SynAct Pharma AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynAct Pharma AB's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynAct Pharma AB's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where SynAct Pharma AB's 3-Year Book Growth Rate falls into.

SynAct Pharma AB 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

SynAct Pharma AB (OSTO:SYNACT) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

SynAct Pharma AB 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of SynAct Pharma AB's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SynAct Pharma AB (OSTO:SYNACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynAct Pharma AB (OSTO:SYNACT) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

8F8:Germany

Address

Sheelevagen 2, Lund, SWE, 223 81

Website

https://www.synactpharma.se

SynAct Pharma AB is a clinical-stage biotech company focused on resolving inflammation through selective activation of the melanocortin system. The company has a platform technology based on a new class of drug candidates that target acute exacerbations in chronic inflammatory diseases with the primary aim of stimulating natural healing mechanisms. AP1189, the company's lead drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.

SynAct Pharma AB (OSTO:SYNACT) Headlines

No Headlines